Your browser doesn't support javascript.
loading
Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase.
Zauderer, Marjorie G; Drilon, Alex; Kadota, Kyuichi; Huberman, Kety; Sima, Camelia S; Bergagnini, Isabella; Sumner, Dyana K; Travis, William D; Heguy, Adriana; Ginsberg, Michelle S; Holodny, Andrei I; Riely, Gregory J; Kris, Mark G; Krug, Lee M; Pietanza, M Catherine.
Afiliación
  • Zauderer MG; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States. Electronic address: zauderem@mskcc.org.
  • Drilon A; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States.
  • Kadota K; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States.
  • Huberman K; Geoffrey Beene Translational Oncology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, United States.
  • Sima CS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, United States.
  • Bergagnini I; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States.
  • Sumner DK; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States.
  • Travis WD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States.
  • Heguy A; Geoffrey Beene Translational Oncology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, United States.
  • Ginsberg MS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, United States.
  • Holodny AI; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, United States.
  • Riely GJ; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States.
  • Kris MG; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States.
  • Krug LM; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States.
  • Pietanza MC; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States.
Lung Cancer ; 86(2): 237-40, 2014 Nov.
Article en En | MEDLINE | ID: mdl-25194640
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antineoplásicos Alquilantes / Dacarbazina / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antineoplásicos Alquilantes / Dacarbazina / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article